China National Medicines Corp Ltd (600511) — Free Cash Flow Generation Index
China National Medicines Corp Ltd (600511) has a Free Cash Flow Generation Index of 0.97x as of June 2025. Free cash flow of CN¥369.51 Million represents 1% of operating cash flow (CN¥382.74 Million). Read China National Medicines Corp Ltd total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China National Medicines Corp Ltd Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for China National Medicines Corp Ltd across 22 annual periods. Explore China National Medicines Corp Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for China National Medicines Corp Ltd (2002–2024)
Year-by-year Free Cash Flow Generation Index for China National Medicines Corp Ltd. For the full company profile including market capitalisation, see China National Medicines Corp Ltd (600511) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.92x | CN¥1.53 Billion | CN¥1.66 Billion | CN¥130.77 Million | ▼ -2.7% |
| 2023 | 0.95x | CN¥2.58 Billion | CN¥2.73 Billion | CN¥145.12 Million | ▲ +0.1% |
| 2022 | 0.95x | CN¥2.27 Billion | CN¥2.40 Billion | CN¥129.78 Million | ▼ -0.6% |
| 2021 | 0.95x | CN¥1.86 Billion | CN¥1.96 Billion | CN¥95.07 Million | ▲ +0.5% |
| 2020 | 0.95x | CN¥1.23 Billion | CN¥1.30 Billion | CN¥69.05 Million | ▼ -0.5% |
| 2019 | 0.95x | CN¥1.69 Billion | CN¥1.78 Billion | CN¥85.72 Million | ▲ +10.0% |
| 2018 | 0.87x | CN¥849.19 Million | CN¥981.65 Million | CN¥132.46 Million | ▼ -7.2% |
| 2017 | 0.93x | CN¥1.00 Billion | CN¥1.07 Billion | CN¥73.25 Million | ▼ -0.1% |
| 2016 | 0.93x | CN¥551.38 Million | CN¥591.25 Million | CN¥39.88 Million | ▲ +10.4% |
| 2015 | 0.84x | CN¥371.82 Million | CN¥440.29 Million | CN¥68.47 Million | ▲ +161.5% |
| 2014 | 0.32x | CN¥70.72 Million | CN¥218.94 Million | CN¥148.22 Million | ▼ -6.2% |
| 2013 | 0.34x | CN¥63.91 Million | CN¥185.56 Million | CN¥121.66 Million | ▲ +294.7% |
| 2012 | 0.09x | CN¥16.22 Million | CN¥185.87 Million | CN¥169.65 Million | ▼ -90.6% |
| 2010 | 0.92x | CN¥294.12 Million | CN¥318.21 Million | CN¥24.09 Million | ▲ +1.3% |
| 2009 | 0.91x | CN¥232.85 Million | CN¥255.18 Million | CN¥22.33 Million | ▼ -1.4% |
| 2008 | 0.93x | CN¥200.89 Million | CN¥217.10 Million | CN¥16.21 Million | ▲ +3.8% |
| 2007 | 0.89x | CN¥70.86 Million | CN¥79.48 Million | CN¥8.61 Million | ▲ +10.9% |
| 2006 | 0.80x | CN¥97.69 Million | CN¥121.50 Million | CN¥23.81 Million | ▲ +45.5% |
| 2005 | 0.55x | CN¥50.96 Million | CN¥92.20 Million | CN¥41.24 Million | ▲ +171.7% |
| 2004 | -0.77x | CN¥-37.90 Million | CN¥49.18 Million | CN¥87.08 Million | ▲ +99.6% |
| 2003 | -171.79x | CN¥-90.39 Million | CN¥526.15K | CN¥90.92 Million | ▼ -260133.2% |
| 2002 | 0.07x | CN¥1.00 Million | CN¥15.19 Million | CN¥14.19 Million | — |